Categories: Technology

Shoals Technologies Group, Inc. Announces Battery Energy Storage Systems (BESS) Webinar

PORTLAND, Tenn., June 30, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced today that it has released a webinar on the subject of Battery Energy Storage Systems (“BESS”), followed by Q&A.

The webinar is intended to be educational and informative. Further, it is being provided to allow customers, investors, analysts and other interested parties to learn more about the BESS market landscape, Shoals’ BESS solutions, Shoals’ paths to market, strategy and competitive position. No financial projections are implied or intended. Featured speakers include Mike Everson, BESS Account Executive, Matt Tractenberg, VP of Finance & Investor Relations, and Lindsey Williams, VP of Marketing & Communications.

You can access the recorded webinar, along with the accompanying presentation, through the Investor Relations section of the Company’s website at https://investors.shoals.com.

About Shoals Technologies Group, Inc.
Shoals Technologies Group is a leading provider of electrical balance of systems (“EBOS”) solutions for the energy transition market. Since its founding in 1996, the Company has introduced innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability. Shoals Technologies Group is a recognized leader in the renewable energy industry. For additional information, please visit: https://www.shoals.com.

Contacts:
Investor Relations:

Matt Tractenberg, VP of Finance and Investor Relations
Email: investors@shoals.com

Media:

Lindsey Williams, VP of Marketing and Communications
Email: lindsey.williams@shoals.com

GlobeNews Wire

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

5 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

5 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

5 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

5 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

5 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

5 hours ago